The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte JOOST VAN NEERVEN
__________
Appeal 2007-1070
Application 09/467,901
Technology Center 1600
__________
Decided: May 22, 2007
__________
Before DONALD E. ADAMS, DEMETRA J. MILLS, and RICHARD M.
LEBOVITZ, Administrative Patent Judges.
LEBOVITZ, Administrative Patent Judge.
DECISION ON APPEAL
This is a decision on appeal from the final rejection of claims 1-6, 8-
14, and 16-23. We have jurisdiction under 35 U.S.C. § 6(b). We affirm.
STATEMENT OF CASE
CD23 and FcεRI were known in the prior art to be the biological
receptors for IgE antibody (Specification 4: 16 to 5: 15). The claimed
invention relates to methods of using these known biological receptors to
detect IgE antibody in a sample.
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next
Last modified: September 9, 2013